Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Allovir, Inc. (ALVR) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/05/2023 4 Brainard Diana (CEO) has filed a Form 4 on Allovir, Inc.
Txns: Sold 1,325 shares @ $1.9763, valued at $2.6k
10/05/2023 4 Sinha Vikas (See Remarks) has filed a Form 4 on Allovir, Inc.
Txns: Sold 755 shares @ $1.9763, valued at $1.5k
10/05/2023 4 Hagen Brett R (Chief Accounting Officer) has filed a Form 4 on Allovir, Inc.
Txns: Sold 222 shares @ $1.9763, valued at $438.7
10/03/2023 144 Form 144 - Report of proposed sale of securities:
10/03/2023 144 Form 144 - Report of proposed sale of securities:
10/03/2023 144 Form 144 - Report of proposed sale of securities:
08/21/2023 4 Sinha Vikas (See Remarks) has filed a Form 4 on Allovir, Inc.
Txns: Sold 10,516 shares @ $2.4955, valued at $26.2k
08/21/2023 4 Brainard Diana (CEO) has filed a Form 4 on Allovir, Inc.
Txns: Sold 11,361 shares @ $2.4955, valued at $28.4k
Sold 4,055 shares @ $2.7898, valued at $11.3k
08/21/2023 4 Hagen Brett R (Chief Accounting Officer) has filed a Form 4 on Allovir, Inc.
Txns: Sold 1,653 shares @ $2.4955, valued at $4.1k
08/18/2023 144 Form 144 - Report of proposed sale of securities:
08/17/2023 144 Form 144 - Report of proposed sale of securities:
08/17/2023 144 Form 144 - Report of proposed sale of securities:
08/17/2023 144 Form 144 - Report of proposed sale of securities:
08/03/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/03/2023 8-K Quarterly results
Docs: "AlloVir Reports Second Quarter 2023 Financial Results"
07/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/20/2023 144 Form 144 - Report of proposed sale of securities:
07/20/2023 144 Form 144 - Report of proposed sale of securities:
07/19/2023 144 Form 144 - Report of proposed sale of securities:
07/19/2023 144 Form 144 - Report of proposed sale of securities:
07/19/2023 144 Form 144 - Report of proposed sale of securities:
07/06/2023 4 Brainard Diana (CEO) has filed a Form 4 on Allovir, Inc.
Txns: Sold 5,275 shares @ $3.0451, valued at $16.1k
07/06/2023 4 Sinha Vikas (See Remarks) has filed a Form 4 on Allovir, Inc.
Txns: Sold 2,983 shares @ $3.0451, valued at $9.1k
07/05/2023 144 Form 144 - Report of proposed sale of securities:
07/05/2023 144 Form 144 - Report of proposed sale of securities:
07/05/2023 4 Piccina Cintia (Chief Commercial Officer) has filed a Form 4 on Allovir, Inc.
Txns: Granted 147,000 shares @ $0
Granted 273,000 options to buy @ $3.24, valued at $884.5k
06/28/2023 4 GILEAD SCIENCES, INC. (10% Owner) has filed a Form 4 on Allovir, Inc.
Txns: Bought 2,930,870 shares @ $3.75, valued at $11M
06/09/2023 144 Form 144 - Report of proposed sale of securities:
05/19/2023 4 Brainard Diana (CEO) has filed a Form 4 on Allovir, Inc.
Txns: Sold 4,536 shares @ $4.214, valued at $19.1k
05/18/2023 144 Form 144 - Report of proposed sale of securities:
05/16/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
05/12/2023 4 Adams Derek N. (Director) has filed a Form 4 on Allovir, Inc.
Txns: Granted 35,000 shares @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy